Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Briggs

Showing results (351-360 of 375) with videos related to

Pageof 38
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.
American Heart Journal|November 7, 2015
Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failureShelby D Reed, Matthew P Neilson, Matthew Gardner, et al.
AJNR. American Journal of Neuroradiology|October 9, 2025
Artificial Intelligence-Driven Detection of Large Vessel Occlusions on NCCT: A Multi-Institutional StudyAnsaar T Rai, Abdulrahman Al Halak, Mohamad Abdalkader, et al.
American Heart Journal|May 3, 2005
Conducting economic evaluations alongside multinational clinical trials: toward a research consensusShelby D Reed, Kevin J Anstrom, Ameet Bakhai, et al.
ERJ Open Research|May 28, 2026
e-Lung computed tomography biomarkers are associated with outcomes in fibrotic interstitial lung diseasesKatharina Abbasi Dezfouli, Anand Devaraj, Finja A Ottink, et al.
Analytical and Bioanalytical Chemistry|February 1, 2007
Development and certification of the new SRM 695 trace elements in multi-nutrient fertilizerE A Mackey, M P Cronise, C N Fales, et al.
Preventive Veterinary Medicine|January 4, 2020
Community Network Integration: An approach to alignment of One Health partners for solutions to 'Wicked' problems of antimicrobial resistanceJ B Wilson, M Salman, E Janzen, et al.
Journal of the American College of Cardiology|May 9, 2020
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES TrialDeepak L Bhatt, Andrew H Briggs, Shelby D Reed, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority TrialTimothy Iveson, Mark P Saunders, Caroline Kelly, et al.
Pageof 38

Showing results (351-360 of 375) with videos related to

Sort By:
Pageof 38
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.
American Heart Journal|November 7, 2015
Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failureShelby D Reed, Matthew P Neilson, Matthew Gardner, et al.
AJNR. American Journal of Neuroradiology|October 9, 2025
Artificial Intelligence-Driven Detection of Large Vessel Occlusions on NCCT: A Multi-Institutional StudyAnsaar T Rai, Abdulrahman Al Halak, Mohamad Abdalkader, et al.
American Heart Journal|May 3, 2005
Conducting economic evaluations alongside multinational clinical trials: toward a research consensusShelby D Reed, Kevin J Anstrom, Ameet Bakhai, et al.
ERJ Open Research|May 28, 2026
e-Lung computed tomography biomarkers are associated with outcomes in fibrotic interstitial lung diseasesKatharina Abbasi Dezfouli, Anand Devaraj, Finja A Ottink, et al.
Analytical and Bioanalytical Chemistry|February 1, 2007
Development and certification of the new SRM 695 trace elements in multi-nutrient fertilizerE A Mackey, M P Cronise, C N Fales, et al.
Preventive Veterinary Medicine|January 4, 2020
Community Network Integration: An approach to alignment of One Health partners for solutions to 'Wicked' problems of antimicrobial resistanceJ B Wilson, M Salman, E Janzen, et al.
Journal of the American College of Cardiology|May 9, 2020
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES TrialDeepak L Bhatt, Andrew H Briggs, Shelby D Reed, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority TrialTimothy Iveson, Mark P Saunders, Caroline Kelly, et al.
Pageof 38